Context Current evidence-based management for clinically localised prostate cancer
includes active surveillance, surgery, external beam radiotherapy (EBRT) and …

Background Evaluation of treatment options for localized prostate cancer (PCa) remains
among the highest priorities for comparative effectiveness research. Surgery and …

Background Robust data on patient-reported outcome measures comparing treatments for
clinically localized prostate cancer are lacking. We investigated the effects of active …

Background Well-documented reports of patients' experiences with different treatments are
important for helping localised prostate cancer (LPC) patients choose among the available …

Purpose Diagnosis and treatment of prostate cancer can generate many challenges which
impact on adjustment, so understanding the psychosocial factors which contribute to …

BACKGROUND Prostate cancer is the most common cancer among men in the UK. Prostate-
specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as …

Background Results from population-based studies and the Prostate Testing for Cancer and
Treatment trial reported worse urinary continence (UC) and erectile function (EF) for radical …

Objectives To present the baseline patient‐reported outcome measures (PROM s) in the
Prostate Testing for Cancer and Treatment (ProtecT) randomized trial comparing active …

Background The aim of this systematic review is to assess the impact of primary treatments
with curative intention in patients with localized prostate cancer, measured with Patient …

Although prostate cancer control using radiotherapy is dose‐dependent, dose–volume
effects on late toxicities in organs at risk, such as the rectum and bladder, have been …